The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of MHB088C, a novel B7-H3-targeted ADC, in patients with relapsed extensive-stage small cell lung cancer (ES-SCLC): Subgroup analysis from a phase 1/2 multicenter study.
 
Lin Shen
No Relationships to Disclose
 
Caicun Zhou
Leadership - IASLC BOD
Honoraria - Akeso Biopharma; Alice; Amoy Diagnostics; Anheart Therapeutics; Hengrui Therapeutics; Innovent Biologics; Lilly; Luye Pharma; Merck Sharpe and Dohme; MSD; QiLu Pharmaceutical; Sanofi; TopAlliance BioSciences Inc
Consulting or Advisory Role - Amoy Diagnostics; Hengrui Therapeutics; Innovent Biologics; QiLu Pharmaceutical; Top Alliance BioScience
 
Yan Yu
No Relationships to Disclose
 
Xinmin Yu
No Relationships to Disclose
 
Xue Meng
No Relationships to Disclose
 
Yuping Sun
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Pfizer; Roche
 
Yuanyuan Ji
No Relationships to Disclose
 
Yinghua Ji
Research Funding - AoSaiKang (Inst); CSPC Pharmaceutical Group (Inst); Hualan Bio (Inst)
 
Fangling Ning
No Relationships to Disclose
 
Yuming Jia
No Relationships to Disclose
 
Haihua Yang
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Qing Wen
No Relationships to Disclose
 
Runxiang Yang
No Relationships to Disclose
 
Yanqiu Zhao
No Relationships to Disclose
 
Liang Han
No Relationships to Disclose
 
Zhiye Zhang
No Relationships to Disclose
 
Shiyu Zhou
No Relationships to Disclose
 
Junwei Shi
No Relationships to Disclose
 
Guoqing Cao
No Relationships to Disclose